Oxidized LDL modulates activation of NFκB in mononuclear phagocytes by altering the degradation of IκBs

被引:32
作者
Hamilton, TA [1 ]
Major, JA [1 ]
Armstrong, D [1 ]
Tebo, JM [1 ]
机构
[1] Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA
关键词
chemokines; gene expression; atherosclerosis;
D O I
10.1002/jlb.64.5.667
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
Oxidized low density lipoprotein (ox-LDL) is known to alter the expression of inflammatory gene products in mononuclear phagocytes. The mechanisms involved in this effect were studied by examining the activation of nuclear factor kappa B (NF kappa B), a transcription factor known to be important in controlling the expression of such genes. Pretreatment of peritoneal macrophages with ox-LDL modulated the activation of NF kappa B in response to either lipopolysaccharide (LPS) or the combination of interferon-gamma (IFN-gamma) and interleukin-2 (IL-2). In macrophages pretreated with oxLDL the nuclear translocation of Rel family members (RelA and c-Rel) is delayed (LPS) or markedly diminished (IFN-gamma/IL-2) and results in delayed or reduced appearance of kappa B binding activity within the nucleus. These changes in NF kappa B activation result from alterations in the stimulus-dependent degradation of I kappa B alpha and I kappa B beta. The effects of oxLDL on NF kappa B activation depend both on the degree of LDL oxidation (most potent with extensive oxidation) and on the time of exposure of the cells to the lipoprotein preparation (a minimal exposure of 6 h is required before inhibitory effects are observed). The modulation of I kappa B/NF kappa B function in cells exposed to oxLDL appears to be responsible for previously reported effects of oxLDL on chemoattractant cytokine gene expression where both inhibition and delay of such stimulus-dependent events has been observed.
引用
收藏
页码:667 / 674
页数:8
相关论文
共 47 条
[1]
Adams D O, 1992, INFLAMMATION BASIC P, P645
[2]
THE CELL BIOLOGY OF MACROPHAGE ACTIVATION [J].
ADAMS, DO ;
HAMILTON, TA .
ANNUAL REVIEW OF IMMUNOLOGY, 1984, 2 :283-318
[3]
Adams DO, 1992, NATURAL IMMUNE SYSTE, P75
[4]
OXIDIZED LDL INDUCES TRANSCRIPTION FACTOR ACTIVATOR PROTEIN-1 BUT INHIBITS ACTIVATION OF NUCLEAR FACTOR-KAPPA-B IN HUMAN VASCULAR SMOOTH-MUSCLE CELLS [J].
ARES, MPS ;
KALLIN, B ;
ERIKSSON, P ;
NILSSON, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (10) :1584-1590
[5]
BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
[6]
BERLINER JA, 1994, ADV EXP MED BIOL, V351, P13
[7]
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[8]
OXIDIZED LDL ENHANCES LIPOPOLYSACCHARIDE-INDUCED TISSUE FACTOR EXPRESSION IN HUMAN ADHERENT MONOCYTES [J].
BRAND, K ;
BANKA, CL ;
MACKMAN, N ;
TERKELTAUB, RA ;
FAN, ST ;
CURTISS, LK .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (05) :790-797
[9]
Dysregulation of monocytic nuclear factor-kappa B by oxidized low-density lipoprotein [J].
Brand, K ;
Eisele, T ;
Kreusel, U ;
Page, M ;
Page, S ;
Haas, M ;
Gerling, A ;
Kaltschmidt, C ;
Neumann, FJ ;
Mackman, N ;
Baeuerle, PA ;
Walli, AK ;
Neumeier, D .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (10) :1901-1909
[10]
MINIMALLY MODIFIED LOW-DENSITY-LIPOPROTEIN INDUCES MONOCYTE CHEMOTACTIC PROTEIN-1 IN HUMAN ENDOTHELIAL-CELLS AND SMOOTH-MUSCLE CELLS [J].
CUSHING, SD ;
BERLINER, JA ;
VALENTE, AJ ;
TERRITO, MC ;
NAVAB, M ;
PARHAMI, F ;
GERRITY, R ;
SCHWARTZ, CJ ;
FOGELMAN, AM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (13) :5134-5138